Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis

Journal of Orthopaedic Research

Volumn 30, Issue 8, 2012, Pages 1249-1253

  Hosogane, Naobumi ^a   Watanabe, Kota ^a   Tsuji, Takashi ^a   Miyamoto, Takeshi ^a   Ishii, Ken ^a   Niki, Yasuo ^a   Nakamura, Masaya ^a   Toyama, Yoshiaki ^a   Chiba, Kazuhiro ^a   Matsumoto, Morio ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

biomarker; degenerative lumbar scoliosis; keratan sulfate; type II collagen

Indexed keywords

BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; HYALURONIC ACID; KERATAN SULFATE; PROCOLLAGEN TYPE II C PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARTILAGE; CONTROLLED STUDY; DEGENERATIVE LUMBAR SCOLIOSIS; FEMALE; HIP; HUMAN; HUMAN TISSUE; KNEE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NUCLEUS PULPOSUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCOLIOSIS; SPINE RADIOGRAPHY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARTILAGE; COLLAGEN TYPE II; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; HYALURONIC ACID; KERATAN SULFATE; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; SCOLIOSIS;

EID: 84862755173     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22067     Document Type: Article

References (24)

1. Aebi M,. 2005. The adult scoliosis. Eur Spine J 14: 925-948.
2. Pritchett JW, Bortel DT,. 1993. Degenerative symptomatic lumbar scoliosis. Spine (PhilaPa 1976) 18: 700-703.
3. Hinek A, Reiner A, Poole AR,. 1987. The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin). J Cell Biol 104: 1435-1441.
4. Shinmei M, Ito K, Matsuyama S, et al. 1993. Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1: 121-128.
5. Croucher LJ, Hollander AP,. 1999. Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage. Mol Pathol 52: 323-331.
6. Kong SY, Stabler TV, Criscione LG, et al. 2006. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum 54: 2496-2504.
7. Thonar EJ, Glant T,. 1992. Serum keratan sulfate- A marker of predisposition to polyarticular osteoarthritis. Clin Biochem 25: 175-180.
8. Cibere J, Zhang H, Garnero P, et al. 2009. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 60: 1372-1380.
9. Kraus VB, Kepler TB, Stabler T, et al. 2010. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS ONE 5: e9739.
10. Addison S, Coleman RE, Feng S, et al. 2009. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation. Arthritis Rheum 60: 3366-3373.
11. Lohmander LS, Saxne T, Heinegard DK,. 1994. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 53: 8-13.
12. Neidhart M, Hauser N, Paulsson M, et al. 1997. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36: 1151-1160.
13. Sharif M, Kirwan JR, Elson CJ, et al. 2004. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 50: 2479-2488.
14. Block JA, Schnitzer TJ, Andersson GB, et al. 1989. The effect of chemonucleolysis on serum keratan sulfate levels in humans. Arthritis Rheum 32: 100-104.
15. Kairemo KJ, Lappalainen AK, Kaapa E, et al. 2001. In vivo detection of intervertebral disk injury using a radiolabeled monoclonal antibody against keratan sulfate. J Nucl Med 42: 476-482.
16. Muralikuttan KP, Adair IV, Roberts G, et al. 1991. Serum keratan sulphate level following chemonucleolysis. Spine (PhilaPa 1976) 16: 1078-1080.
17. Kellgren JH, Lawrence JS,. 1957. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16: 494-502.
18. Muraki S, Akune T, Oka H, et al. 2010. Impact of knee and low back pain on health-related quality of life in Japanese women: the Research on Osteoarthritis Against Disability (ROAD). Mod Rheumatol 20: 444-451.
19. Wakitani S, Nawata M, Kawaguchi A, et al. 2007. Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology (Oxford) 46: 1652-1656.
20. Lohmander LS, Yoshihara Y, Roos H, et al. 1996. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. J Rheumatol 23: 1765-1769.
21. Nelson F, Dahlberg L, Laverty S, et al. 1998. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102: 2115-2125.
22. Conrozier T, Poole AR, Ferrand F, et al. 2008. Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis. Clin Exp Rheumatol 26: 430-435.
23. Meulenbelt I, Kloppenburg M, Kroon HM, et al. 2007. Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. Osteoarthritis Cartilage 15: 379-385.
24. Ishijima M, Watari T, Naito K, et al. 2011. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res Ther 13: R22.